These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 709565)

  • 21. Subendocardial late gadolinium enhancement in two patients with anthracycline cardiotoxicity following treatment for Ewing's sarcoma.
    Perel RD; Slaughter RE; Strugnell WE
    J Cardiovasc Magn Reson; 2006; 8(6):789-91. PubMed ID: 17060100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of mtDNA lesions in anthracycline cardiotoxicity.
    Lebrecht D; Walker UA
    Cardiovasc Toxicol; 2007; 7(2):108-13. PubMed ID: 17652814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical evaluation of the cardiac toxicity of 4'-deoxy-doxorubicin.
    Villani F; Galimberti M; Comazzi R; Crippa F; Bonfante V; Ferrari L; Pacciarini MA
    Int J Clin Pharmacol Ther Toxicol; 1988 Apr; 26(4):185-9. PubMed ID: 3403095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiotoxicity and anthracyclines.
    Stebbing J; Jones A; Barrett-Lee P
    Breast Cancer Res Treat; 2008 Feb; 107(3):451-3. PubMed ID: 18167621
    [No Abstract]   [Full Text] [Related]  

  • 25. Ultrastructural morphometric analysis of endomyocardial biopsies. Idiopathic dilated cardiomyopathy, anthracycline cardiotoxicity, and normal myocardium.
    Rowan RA; Masek MA; Billingham ME
    Am J Cardiovasc Pathol; 1988; 2(2):137-44. PubMed ID: 3061409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of anthracyclines in the era of targeted therapy.
    Cortés-Funes H; Coronado C
    Cardiovasc Toxicol; 2007; 7(2):56-60. PubMed ID: 17652804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiotoxicity of cytotoxic chemotherapy and its prevention.
    Selvaratnam G; Philips RH; Mohamed AK
    Adverse Drug React Toxicol Rev; 1999 Jun; 18(2):61-105. PubMed ID: 10478286
    [No Abstract]   [Full Text] [Related]  

  • 28. Endomyocardial biopsy to monitor anthracycline therapy in children.
    Pegelow CH; Popper RW; de Wit SA; King OY; Wilbur JR
    J Clin Oncol; 1984 May; 2(5):443-6. PubMed ID: 6587017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radionuclide angiography for the evaluation of anthracycline therapy.
    Kennedy JW; Sorensen SG; Ritchie JL; Folland ED; Hamilton GW
    Cancer Treat Rep; 1978 Jun; 62(6):941-3. PubMed ID: 667872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cardiotoxicity of anthracyclines].
    Laurent S; Colbert N; Izrael V; Motte G
    Ann Med Interne (Paris); 1984; 135(6):464-72. PubMed ID: 6391323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment for asymptomatic anthracycline-induced cardiac dysfunction in childhood cancer survivors: the need for evidence.
    van Dalen EC; van der Pal HJ; van den Bos C; Caron HN; Kremer LC
    J Clin Oncol; 2003 Sep; 21(17):3377; author reply 3377-8. PubMed ID: 12947081
    [No Abstract]   [Full Text] [Related]  

  • 32. Strategies for prevention of anthracycline cardiotoxicity.
    Basser RL; Green MD
    Cancer Treat Rev; 1993 Jan; 19(1):57-77. PubMed ID: 8431927
    [No Abstract]   [Full Text] [Related]  

  • 33. [Cardiotoxicity of anthracyclines. Apropos of 12 pediatric cases].
    Favrot MC; Pouyau G; Souillet G; Philip T; Bozzio A; Philippe N
    Pediatrie; 1981 Sep; 36(6):437-50. PubMed ID: 6947199
    [No Abstract]   [Full Text] [Related]  

  • 34. [Cardiotoxicity of anthracycline].
    Wojtukiewicz MZ; Omyła J; Kozłowski L; Szynaka B
    Postepy Hig Med Dosw; 2000; 54(4):467-85. PubMed ID: 11016267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term and short-term models for studying anthracycline cardiotoxicity and protectors.
    Robert J
    Cardiovasc Toxicol; 2007; 7(2):135-9. PubMed ID: 17652818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A drug for prevention of anthracycline-induced cardiac toxicity.
    Med Lett Drugs Ther; 1991 Sep; 33(852):85-6. PubMed ID: 1908544
    [No Abstract]   [Full Text] [Related]  

  • 37. [Endomyocardial biopsy].
    Mosseri M; Gotsman SM; Hasin Y
    Harefuah; 1988 May; 114(9):445-8. PubMed ID: 3294141
    [No Abstract]   [Full Text] [Related]  

  • 38. The quantitative structure-selectivity relationship of anthracycline antitumor activity and cardiac toxicity.
    Fink SI; Leo A; Yamakawa M; Hansch C; Quinn FR
    Farmaco Sci; 1980 Dec; 35(12):965-79. PubMed ID: 7202703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cardiotoxicity of anthracyclines].
    Ferrière M; Donadio D; Ramirez R
    Arch Mal Coeur Vaiss; 1993 Feb; 86 Spec No 2():53-8. PubMed ID: 8215791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The anthracycline cardiotoxicity debate.
    Finlay J; Meadows AT
    Pediatrics; 1994 Nov; 94(5):780-1; author reply 781-2. PubMed ID: 7936925
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.